CD8A and neoplasm: Importantly, the fecal microbiota transplantation (FMT) from human responders to ICI therapy led to reduced tumor growth, an increasing number of intratumoral CD8+ T cells and the enhanced efficacy of PD-1/PD-L1 blockade in mice [32,33,34].